Overview

Confront the urgent unmet challenge of hard-to-control hypertension and its dire implications for cardiovascular and kidney health. Despite existing treatments, high mortality and complications persist. This presentation reveals cutting-edge insights into the pathogenic effects of aldosterone excess as an unaddressed driver of hypertension, contributing to heart failure, cardiovascular disease, and chronic kidney disease. Be part of the conversation to ignite a transformative dialogue on redefining hypertension management.

SPONSORED BY

AstraZeneca (Main Account)